SOP Guide for Pharma

Analytical Method Development: SOP for Handling Method Development Failures – V 2.0

Analytical Method Development: SOP for Handling Method Development Failures – V 2.0

Standard Operating Procedure for Managing Method Development Failures in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/348/2025
Supersedes SOP/AMD/348/2022
Page No. Page 1 of 14
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to define a standardized procedure for identifying, documenting, analyzing, and addressing failures that occur during analytical method development (AMD) activities. The objective is to ensure continuous improvement, compliance

with regulatory expectations, and scientific justification of failures and their resolutions.

2. Scope

This SOP is applicable to all AMD activities conducted in the laboratory where method development fails to meet predefined criteria such as specificity, precision, accuracy, linearity, robustness, or system suitability. It covers failures related to instrumentation, method parameters, reagents, and sample matrices.

3. Responsibilities

  • Method Developer: Identifies failure, halts activity, and initiates failure report.
  • AMD Supervisor: Conducts preliminary assessment and assigns investigation responsibilities.
  • Quality Assurance (QA): Reviews investigation findings and ensures CAPA implementation.
  • Instrument Engineer (if applicable): Supports technical diagnostics for instrument-related failures.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the integrity of the method development process and the scientific handling of failures in compliance with cGMP and ICH guidelines.

5. Procedure

5.1 Identification of Failure

  1. Recognize method development failure when observed results deviate significantly from expected trends or acceptance criteria.
  2. Failures may include abnormal chromatograms, poor peak resolution, unstable results, inconsistent recovery, or lack of linearity.
  3. Stop the method development activity immediately upon identification of failure.

5.2 Documentation and Intimation

  1. Record details of the failure in Annexure-1: Method Development Failure Report Form.
  2. Include method ID, analyst name, date, instrument used, reagent details, and brief observations.
  3. Notify AMD supervisor and QA immediately through internal communication channel.

5.3 Root Cause Investigation

  1. Initiate root cause analysis (RCA) using structured tools such as Fishbone diagram or 5 Whys technique.
  2. Investigate parameters such as reagent integrity, instrument performance, column condition, method variables (pH, mobile phase composition), and analyst technique.
  3. Document all findings in Annexure-2: RCA Worksheet and classify cause as assignable or unassignable.

5.4 Categorization of Failure

  • Instrumental Failure: Malfunction of detector, pump, injector, or temperature controls.
  • Reagent/Column Issues: Expired, contaminated, or incorrectly prepared reagents or degraded column.
  • Method Parameter-Related: Inappropriate gradient, pH, flow rate, or detection wavelength.
  • Human Error: Incorrect preparation, sampling, calculation, or sequence setup.

5.5 Corrective and Preventive Action (CAPA)

  1. Based on RCA, propose CAPA with defined timelines and responsible personnel.
  2. Implement corrective measures (e.g., recalibration, retraining, column replacement, method optimization).
  3. Preventive actions may include checklist revision, SOP update, or additional system suitability tests.
  4. Record all CAPAs in Annexure-3: CAPA Implementation Log.

5.6 Reinitiation of Method Development

  1. After CAPA implementation, reinitiate method development using controlled parameters.
  2. Compare results with prior failed attempt and confirm performance improvement.
  3. Attach method revalidation outcome to the failure report and archive complete package.

6. Abbreviations

  • CAPA: Corrective and Preventive Action
  • RCA: Root Cause Analysis
  • cGMP: Current Good Manufacturing Practice
  • AMD: Analytical Method Development

7. Documents

  1. Annexure-1: Method Development Failure Report Form
  2. Annexure-2: RCA Worksheet
  3. Annexure-3: CAPA Implementation Log

8. References

  • ICH Q9 – Quality Risk Management
  • ICH Q2(R1) – Validation of Analytical Procedures
  • 21 CFR Part 211 – GMP for Finished Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Akshay Verma Nidhi Rawat Dr. Arvind Bansal
Designation AMD Executive QA Officer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Method Development Failure Report Form

Captures method details, failure description, affected parameter(s), environmental conditions, and initial analyst comments.

Annexure-2: Root Cause Analysis (RCA) Worksheet

Structured documentation using fishbone diagram, listing probable causes under categories like Material, Instrument, Method, Analyst, and Environment.

Annexure-3: CAPA Implementation Log

CAPA ID Description Responsible Person Timeline Status
CAPA-AMD-348-01 Retraining on pH adjustment techniques Training Officer 10 Days Completed

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Expanded sections on CAPA and RCA tools Annual SOP Review Dr. Arvind Bansal
15/05/2022 1.0 Initial Release New SOP QA Head
Exit mobile version